تعديل

jeudi 31 mars 2016

Regeneron, Sanofi eczema drug clears hurdles in big trials

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi said on Friday their experimental treatment for eczema proved highly effective in two large studies, without serious side effects often seen with standard treatments for the chronic inflammatory skin disease.


http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro

Aucun commentaire:

Enregistrer un commentaire